BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 38203637)

  • 1. Statins-From Fungi to Pharmacy.
    Sadowska A; Osiński P; Roztocka A; Kaczmarz-Chojnacka K; Zapora E; Sawicka D; Car H
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.
    Manzoni M; Rollini M
    Appl Microbiol Biotechnol; 2002 Apr; 58(5):555-64. PubMed ID: 11956737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploitation of Aspergillus terreus for the Production of Natural Statins.
    Subhan M; Faryal R; Macreadie I
    J Fungi (Basel); 2016 Apr; 2(2):. PubMed ID: 29376930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compactin-a review.
    Chakravarti R; Sahai V
    Appl Microbiol Biotechnol; 2004 Jun; 64(5):618-24. PubMed ID: 15034683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.
    Perchellet JP; Perchellet EM; Crow KR; Buszek KR; Brown N; Ellappan S; Gao G; Luo D; Minatoya M; Lushington GH
    Int J Mol Med; 2009 Nov; 24(5):633-43. PubMed ID: 19787197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activity of statins against Aspergillus species.
    Qiao J; Kontoyiannis DP; Wan Z; Li R; Liu W
    Med Mycol; 2007 Nov; 45(7):589-93. PubMed ID: 18033614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotechnological Production of Statins: Metabolic Aspects and Genetic Approaches.
    Neto RNM; de Barros Gomes E; Weba-Soares L; Dias LRL; da Silva LCN; de Miranda RCM
    Curr Pharm Biotechnol; 2019; 20(15):1244-1259. PubMed ID: 31333127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins and asthma].
    Pawlak J; Ziętkowski Z; Bodzenta-Łukaszyk A
    Postepy Hig Med Dosw (Online); 2011 Mar; 65():177-89. PubMed ID: 21502694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of macrophage elastase (MMP-12) gene expression by statins.
    Arikan MC; Shapiro SD; Mariani TJ
    J Cell Physiol; 2005 Jul; 204(1):139-45. PubMed ID: 15605420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
    Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
    J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
    Williams D; Feely J
    Clin Pharmacokinet; 2002; 41(5):343-70. PubMed ID: 12036392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.
    Mausner-Fainberg K; Luboshits G; Mor A; Maysel-Auslender S; Rubinstein A; Keren G; George J
    Atherosclerosis; 2008 Apr; 197(2):829-39. PubMed ID: 17826781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
    Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
    Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a role for statins in immunomodulation.
    Mach F
    Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
    Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
    J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.